{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:01:48Z","timestamp":1793152908091,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2020-043"],"award-info":[{"award-number":["2020-043"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"DOI":"10.1038\/s41597-026-07380-3","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:25:51Z","timestamp":1779125151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-cell transcriptomic profiling of patient-derived pancreatic ductal adenocarcinoma primary cell cultures"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5556-4385","authenticated-orcid":false,"given":"Vladimir","family":"Chocoloff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Moubri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Roques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-3217","authenticated-orcid":false,"given":"Philippe","family":"Soubeyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2237","authenticated-orcid":false,"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Dusetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fraunhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"7380_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"7380_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"7380_CR3","doi-asserted-by":"crossref","unstructured":"Dusetti, N. et al. Medical management of pancreatic cancer: from personalization to broadening treatment strategies. Cancer Treat. Rev. 138 (2025).","DOI":"10.1016\/j.ctrv.2025.102973"},{"key":"7380_CR4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang, W. L. et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nature Genetics 54, 1178\u20131191 (2022).","journal-title":"Nature Genetics"},{"key":"7380_CR5","doi-asserted-by":"publisher","first-page":"102479","DOI":"10.1016\/j.tranon.2025.102479","volume":"60","author":"J Iovanna","year":"2025","unstructured":"Iovanna, J., Fraunhoffer, N., Urrutia, R. & Dusetti, N. Understanding the heterogeneity of pancreatic ductal adenocarcinoma. Transl. Oncol. 60, 102479 (2025).","journal-title":"Transl. Oncol."},{"key":"7380_CR6","doi-asserted-by":"publisher","unstructured":"Juiz, N. A., Iovanna, J. & Dusetti, N. Pancreatic cancer heterogeneity can be explained beyond the genome. Frontiers in Oncology 9, 246, https:\/\/doi.org\/10.3389\/fonc.2019.00246 (2019).","DOI":"10.3389\/fonc.2019.00246"},{"key":"7380_CR7","doi-asserted-by":"publisher","unstructured":"Fraunhoffer, N. A., Abuelafia, A. M., Dusetti, N. & Iovanna, J. Limitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool. 1\u20134, https:\/\/doi.org\/10.1002\/cac2.12335 (2022).","DOI":"10.1002\/cac2.12335"},{"key":"7380_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.annonc.2020.10.601","volume":"32","author":"R Nicolle","year":"2021","unstructured":"Nicolle, R. et al. A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. Annals of Oncology 32, 250\u2013260 (2021).","journal-title":"Annals of Oncology"},{"key":"7380_CR9","doi-asserted-by":"publisher","unstructured":"Fraunhoffer, N. et al. A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma. Gastroenterology 476\u2013480, https:\/\/doi.org\/10.1053\/j.gastro.2022.11.035 (2022).","DOI":"10.1053\/j.gastro.2022.11.035"},{"key":"7380_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2024.1437200","volume":"14","author":"N Fraunhoffer","year":"2024","unstructured":"Fraunhoffer, N. et al. Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer. Front. Oncol. 14, 1\u20139 (2024).","journal-title":"Front. Oncol."},{"key":"7380_CR11","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/1078-0432.CCR-20-1232","volume":"26","author":"NA Fraunhoffer","year":"2020","unstructured":"Fraunhoffer, N. A. et al. Evidencing a pancreatic ductal adenocarcinoma subpopulation sensitive to the proteasome inhibitor carfilzomib. Clinical Cancer Research 26, 5506\u20135519 (2020).","journal-title":"Clinical Cancer Research"},{"key":"7380_CR12","doi-asserted-by":"crossref","unstructured":"Fraunhoffer, N. A. et al. Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction. NPJ Precis. Oncol. 6 (2022).","DOI":"10.1038\/s41698-022-00299-z"},{"key":"7380_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104602","volume":"92","author":"NA Fraunhoffer","year":"2023","unstructured":"Fraunhoffer, N. A. et al. Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells. EBioMedicine 92, 104602 (2023).","journal-title":"EBioMedicine"},{"key":"7380_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103332","author":"AE Kaoutari","year":"2021","unstructured":"Kaoutari, A. E. et al. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. EbioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2021.103332 (2021).","journal-title":"EbioMedicine"},{"key":"7380_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1126\/science.aam8999","volume":"360","author":"AB Rosenberg","year":"2018","unstructured":"Rosenberg, A. B. et al. Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding. Science 360, 176\u2013182 (2018).","journal-title":"Science"},{"key":"7380_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.gastro.2004.03.058","volume":"127","author":"FS Schreiber","year":"2004","unstructured":"Schreiber, F. S. et al. Successful growth and characterization of mouse pancreatic ductal cells: Functional properties of the Ki-RASG12V oncogene. Gastroenterology 127, 250\u201360 (2004).","journal-title":"Gastroenterology"},{"key":"7380_CR17","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"7380_CR18","doi-asserted-by":"publisher","first-page":"e1009290","DOI":"10.1371\/journal.pcbi.1009290","volume":"17","author":"AA Hippen","year":"2021","unstructured":"Hippen, A. A. et al. miQC: An adaptive probabilistic framework for quality control of single-cell RNA-sequencing data. PLoS Comput. Biol. 17, e1009290 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"7380_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","volume":"26","author":"NU Rashid","year":"2020","unstructured":"Rashid, N. U. et al. Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer. Clinical Cancer Research 26, 82\u201392 (2020).","journal-title":"Clinical Cancer Research"},{"key":"7380_CR20","doi-asserted-by":"crossref","unstructured":"Chocoloff, V. et al. Single-cell transcriptomic profiling of patient- derived pancreatic ductal adenocarcinoma primary cell cultures. https:\/\/www.ebi.ac.uk\/biostudies\/arrayexpress\/studies\/E-MTAB-16856 (2026).","DOI":"10.1038\/s41597-026-07380-3"},{"key":"7380_CR21","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.stem.2024.10.016","volume":"31","author":"ND Amin","year":"2024","unstructured":"Amin, N. D. et al. Generating human neural diversity with a multiplexed morphogen screen in organoids. Cell Stem Cell 31, 1831\u20131846.e9 (2024).","journal-title":"Cell Stem Cell"},{"key":"7380_CR22","doi-asserted-by":"crossref","unstructured":"Shiau, C. et al. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Nature Genetics 2024 56:11 56, 2466\u20132478 (2024).","DOI":"10.1038\/s41588-024-01890-9"}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41597-026-07380-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-026-07380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-026-07380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:03:52Z","timestamp":1786100632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41597-026-07380-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7380"],"URL":"https:\/\/doi.org\/10.1038\/s41597-026-07380-3","relation":{},"ISSN":["2052-4463"],"issn-type":[{"value":"2052-4463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ND and JI are co-founders of Predicting Med. ND, NF and JI are inventors for the patent PCT\/EP2022\/065222: Simple transcriptomic signatures to determine chemosensitivity for pancreatic ductal adenocarcinoma. SATT Sud-Est.: 2021. Licensing to Predicting Med.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1145"}}